MDA-MB-231 tumor aggregate growth after CAR-T cell treatment in comparison with (control) T cell treatment, as measured by quantifying the percentage change in each MDA-MB-231 aggregate area between certain time points and the initial area before (CAR-)T cell perfusion;n= 12–16 aggregates from 4 chips. Data are presented as the mean ± SEM.